The COVID-19 pandemic has disrupted the routine of in-person events, the need for sharing information and building key supplier connections for bio/pharmaceutical development and manufacturing has never been greater.

 The 2020 Bio/Pharma Virtual Congress event will connect bio/pharma formulation, development, manufacturing, and quality experts with a full day of technical presentations, panel discussions, interviews, and vendor meetings, through an interactive portal. 

 This online event will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. 

On-Demand

Anytime

Your Computer

Four Interactive Tracks

Emerging technologies and processes that impact, enable, and advance bio/pharmaceutical development and manufacturing will be explored in Editors’ Series panel discussions and technical session presented by industry experts in four topic areas:

The COVID-19 pandemic has disrupted the routine of in-person events, the need for sharing information and building key supplier connections for bio/pharmaceutical development and manufacturing has never been greater.

 The 2020 Bio/Pharma Virtual Congress event will connect bio/pharma formulation, development, manufacturing, and quality experts with a full day of technical presentations, panel discussions, interviews, and vendor meetings, through an interactive portal. 

 This online event will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. 

Keynote Panel Discussions

The bio/pharma industry has demonstrated its R&D capabilities by accelerating development of vaccines and therapeutics to combat COVID-19. At the same time the industry faced intense scrutiny and political pressure. What are the short-, medium-, and long-term implications for bio/pharma development and manufacturing? Representatives of PhRMA, BIO, and other industry organizations will discuss and debate crucial business, regulatory, science-based issues facing the industry.

Supporting Sponsor:

Sponsors:

Schedule at a Glance

Wednesday, November 11th

8:30 a.m. _____________________________________________________________ 
9:00 a.m. ______________________________________________________________
9:45 a.m_________________________________________________
10:00 a.m._______________________________________________________
11:00 a.m._______________________________________________ 
11:30 a.m._______________________________________________________ 
12:30 p.m._______________________________________________ 
1:30 p.m._______________________________________________________
2:30 p.m._________________________________________________
3:00 p.m._______________________________________________________
4:00 p.m.________________________________________________________________

Registration Opens 
 Keynote Speaker
Networking Break in Exhibit Hall  
Track Breakout Sessions 
Networking Break in Exhibit Hall 
Track Breakout Sessions 
Networking Break in Exhibit Hall 
Track Breakout Sessions
Networking Break in Exhibit Hall
Track Breakout Sessions 
Event Close

November 11, 2020

8:30 am to 4:00 pm ET

Your Computer

Featured Speakers

FORMULATION

Topics included in this session are drug development, drug delivery, APIs, excipients, formulation trends, modified release, injectable drug formulation, and more.

Session 1: Improving Patient Outcomes through the Stratum Technology Platform: Revolutionized Injectable Solutions 

Session 2: Data-Driven Strategies to Accelerate Your Molecule’s Development Path

Session 3: Excipients Update: Formulations, Supply, and Quality

Session 4: When Drug Meets Device: How to Assess Compatibility

MANUFACTURING

Topics included in this session are manufacturing strategies, process analytical technology, process and operational intelligence, data integrity, predictive maintenance, scale up, 
fluid-bed coating, and more

Session 1: The Future of Life Sciences Production Automation: Greater Visibility with Audit-Ready Solutions

Session 2: Technology Advances in Process Operations: Using Real-time Monitoring and Artificial Intelligence to Optimize Manufacturing Operations

Session 3: End Point Determination and Scale-up of Fluid Bed Coating Through the Use of Process Tools 

Session 4: 21CFR part 11 Data Integrity Challenges for Cleanroom Routine Environmental Monitoring Programs

DRUG DOSAGE FORM TRENDS

Topics include in this session are vaccines, biologics, solid dosage drugs, controlled release, cell and gene therapies, and more.

Session 1: Delivering on the Promise: Overcoming Biopharma Development and Manufacturing Challenges 

Session 2: Mapping the Transition from Drug Discovery to Development and Beyond 

Session 3: Editors’ Series: Genotoxic Impurities and Drug Quality: Lessons from the Nitrosamine Contamination Crisis 

Session 4: Demystifying AI in Pharma 

BIOPHARMA INDUSTRY CHALLENGES

Topics included in this sessions are drug quality, regulatory inspections, COVID-19 pandemic impact, good manufacturing practices, regulated documents, and more

Session 1: Cleanrooms Qualification Vs Cleanroom Monitoring: Annex 1 V12 Requirements 

Session 2: Ensuring Container Closure Integrity of Sterile Vials 

Session 3: Establishing a “New Normal” for Pharma Quality Practices 

Session 4: Expedite Regulated Documents in the Era of COVID-19: From Development to Trials and Manufacturing

Keynote Panel Discussion

The bio/pharma industry has demonstrated its R&D capabilities by accelerating development of vaccines and therapeutics to combat COVID-19. At the same time the industry faced intense scrutiny and political pressure. What are the short-, medium-, and long-term implications for bio/pharma development and manufacturing? Representatives of PhRMA, BIO, and other industry organizations will discuss and debate crucial business, regulatory, science-based issues facing the industry.